Center for Drug Evaluation and Research (CDER) discusses how they execute emergency preparedness and response to public health incidents, including medical countermeasure (MCM) development programs, with highlights from both past public health emergencies and the current COVID-19 pandemic response.



Presenters:

Kelly Ngan, PharmD,

CDR, USPHS

Team Leader

Project Management and Emergency Coordination



Andrea Gormley, PharmD

LCDR, USPHS

Associate Director for Regulatory Affairs



Counter-Terrorism and Emergency Coordination Staff (CTECS)

Office of the Center Director, CDER



Learn More at: [ Ссылка ]



_______________________________  
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.   

  

Upcoming Training - [ Ссылка ]

SBIA Listserv - [ Ссылка ]

SBIA 2021 Playlist - [ Ссылка ]

SBIA LinkedIn - [ Ссылка ]

SBIA Training Resources - [ Ссылка ]

Twitter - [ Ссылка ]

Email - CDERSBIA@fda.hhs.gov

Phone - (301) 796-6707 I (866) 405-5367

свернуть